Duke University School of Medicine, Durham, North Carolina, USA.
Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
World Neurosurg. 2023 Dec;180:e449-e459. doi: 10.1016/j.wneu.2023.09.087. Epub 2023 Sep 26.
Preoperative assessment is important for neurosurgical risk stratification, but the level of evidence for individual screening tests is low. In preoperative urinalysis (UA), testing may significantly increase costs and lead to inappropriate antibiotic treatment. We prospectively evaluated whether eliminating preoperative UA was noninferior to routine preoperative UA as measured by 30-day readmission for surgical site infection in adult elective neurosurgical procedures.
A single-institution prospective, pragmatic study of patients receiving elective neurosurgical procedures from 2018 to 2020 was conducted. Patients were allocated based on same-day versus preoperative admission status. Rates of preoperative UA and subsequent wound infection were measured along with detailed demographic, surgical, and laboratory data.
The study included 879 patients. The most common types of surgery were cranial (54.7%), spine (17.4%), and stereotactic/functional (19.5%). No preoperative UA was performed in 315 patients, while 564 underwent UA. Of tested patients, 103 (18.3%) met criteria for suspected urinary tract infection, and 69 (12.2%) received subsequent antibiotic treatment. There were 14 patients readmitted within 30 days (7 without UA [2.2%] vs. 7 with UA [1.2%]) for subsequent wound infection with a risk difference of 0.98% (95% confidence interval -0.89% to 2.85%). The upper limit of the confidence interval exceeded the preselected noninferiority margin of 1%.
In this prospective study of preoperative UA for elective neurosurgical procedures using a pragmatic, real-world design, risk of readmission due to surgical site infection was very low across the study cohort, suggesting a limited role of preoperative UA for elective neurosurgical procedures.
术前评估对神经外科风险分层很重要,但个别筛查试验的证据水平较低。在术前尿分析(UA)中,检测可能会显著增加成本,并导致不适当的抗生素治疗。我们前瞻性评估了在成人择期神经外科手术中,是否可以通过 30 天内因手术部位感染再次入院的情况,来衡量消除术前 UA 是否不劣于常规术前 UA。
这是一项单中心前瞻性、实用研究,纳入了 2018 年至 2020 年接受择期神经外科手术的患者。患者按当天入院与术前入院的状态进行分配。测量了术前 UA 和随后的伤口感染的发生率,并详细记录了人口统计学、手术和实验室数据。
该研究共纳入 879 例患者。最常见的手术类型为颅脑(54.7%)、脊柱(17.4%)和立体定向/功能(19.5%)。315 例患者未行术前 UA,564 例行 UA。在接受检测的患者中,有 103 例(18.3%)符合疑似尿路感染的标准,69 例(12.2%)接受了后续抗生素治疗。有 14 例患者在 30 天内再次入院(无 UA 者 7 例[2.2%],有 UA 者 7 例[1.2%]),因随后的伤口感染再次入院,风险差异为 0.98%(95%置信区间-0.89%至 2.85%)。置信区间的上限超过了预先设定的非劣效性边界 1%。
在这项使用实用、真实世界设计的择期神经外科手术术前 UA 的前瞻性研究中,整个研究队列中因手术部位感染再次入院的风险非常低,这表明术前 UA 在择期神经外科手术中的作用有限。